BDTXBlack Diamond Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Black Diamond Therapeutics, Inc. against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BDTXEsta | $113M#5 | — | 1.2x#2 | 1.6x#2 | — | 132.1%#2 | 17.9%#2 | 23276.9%#1 | — | — | — | — |
| CRBU | $140M#3 | — | 1.4x#3 | 12.5x#4 | 11.7%#1 | 0.7%#3 | -1329.4%#4 | -151.0%#3 | — | — | — | — |
| ENGN | $127M#4 | 0.8x#1 | 0.6x#1 | — | — | -112.7%#4 | — | -50.9%#2 | — | — | -69.6%#2 | — |
| ATTO | $1.1B#1 | — | — | — | — | — | — | — | — | — | — | — |
| ATRA | $100M#6 | — | — | 0.8x#1 | -6.3%#2 | 138.3%#1 | 29.7%#1 | — | — | — | -16.2%#1 | — |
| PTHS | $84M#7 | — | — | 5.0x#3 | — | -444.6%#5 | -193.1%#3 | — | — | — | — | — |
| SCTX | $615M#2 | — | — | — | — | — | — | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice